Tango Therapeutics, Inc. (TNGX) Misses Q2 EPS by 5c

Tango Therapeutics, Inc. (NASDAQ: TNGX) reported Q2 EPS of ($0.37), $0.05 worse than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Tango Therapeutics, Inc. (TNGX) click here.

You May Also Be Interested In

• Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
• General Mills beats estimates as cost savings offset volumes
• Disney+ pricing to increase 13% to $21.49/mo